INITS Group
INITS Group is a French consulting and SMO bioproduction firm serving biotech companies with CMC, regulatory, IMP, QA, and clinical bioproduction support. Founded in 2013 in Montpellier with 11–50 employees, it has served 250+ international clients.
- Company typePrivate
- Founded2013
- HeadquartersMontpellier, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What INITS Group does
INITS Group is a privately held French professional services firm headquartered in Montpellier that supports biotechnology companies across the pharmaceutical value chain. Founded in 2013, the firm operates with 11–50 employees and reports having served 250+ international clients, conducted 300+ audits, completed 50+ IMPD/IND writing reviews, managed 50+ CMC projects, and developed 100+ quality management systems (QMS). Its core clients are biotech companies needing expert guidance on regulatory strategy, CMC, investigational medicinal product (IMP) documentation, and quality assurance.
The company operates two interconnected service lines. The Consulting Services line delivers focused or comprehensive support across CMC, regulatory affairs, IMP, and QA workstreams, including regulatory dossier preparation and submission to authorities such as the EMA. The SMO (Shared Manufacturing Organization) line provides a dedicated bioproduction unit with infrastructure and experienced staff to support preclinical and clinical trial manufacturing for biotech clients that lack in-house production capacity.
INITS monetizes through professional services engagements and managed services (SMO), with quote-based pricing that is not publicly disclosed. It goes to market via a sales-led, direct-engagement model targeting enterprise biotech accounts, supplemented by content marketing through its corporate website. The firm shows no evidence of external funding, M&A activity, or AI/technology platform development, and ownership and management team details are not disclosed in available sources.
INITS Group firmographics
Firmographics- Name
- INITS Group
- Legal name
- INITS
- Website
- https://inits-group.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- INITS Group is a French consulting and SMO bioproduction firm serving biotech companies with CMC, regulatory, IMP, QA, and clinical bioproduction support. Founded in 2013 in Montpellier with 11–50 employees, it has served 250+ international clients.
- Ownership category
- akta.pro rank
INITS Group industry classification
Industry- Product category
- Pharmaceutical Consulting
- NAICS
- Management Consulting Services (54161)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)
- akta.pro secondary industries
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC), Manufacturing, MSAT & Operations Staffing (API/Biologics/Cell & Gene) (HLAGAOAL)
Keywords
Where INITS Group is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
INITS Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Consulting Services: Professional consulting services providing focused expertise or comprehensive support across the pharmaceutical value chain including CMC, regulatory, IMP, and QA support
- SMO Services: Shared Manufacturing Organization services providing dedicated bioproduction unit access for preclinical and clinical trial support
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
INITS Group product offering
Product offeringCore offering
INITS Group is a French service firm that provides consulting and a Shared Manufacturing Organization (SMO) offering to biotech and pharmaceutical companies. It delivers expertise across the pharmaceutical value chain in CMC (Chemistry, Manufacturing, and Controls), regulatory affairs, IMP (Investigational Medicinal Product) support, and quality assurance, and operates a dedicated bioproduction unit for preclinical and clinical trial material production.
Product overview
INITS Group offers two interconnected core service offerings: Consulting Services and SMO (Shared Manufacturing Organization). The Consulting Services provide comprehensive pharmaceutical value chain support including CMC, regulatory affairs, IMP, and quality assurance support. The SMO service provides dedicated bioproduction infrastructure and expertise for preclinical and clinical trials. Together, these services enable biotech companies to advance medicines from development through regulatory submission, with INITS supporting both the technical/regulatory expertise (Consulting) and the physical bioproduction capabilities (SMO).
Differentiator
Problem solved
Functional benefit
Products and services
- Consulting Services Professional consulting providing focused expertise or comprehensive support across the entire pharmaceutical value chain for biotech companies, covering CMC, regulatory affairs, IMP support, and quality assurance.
- SMO (Shared Manufacturing Organization) A dedicated bioproduction unit providing infrastructure and experienced team support for preclinical and clinical trial material production, enabling biotech companies to advance their medicine development through critical trial phases.
Quantifiable outcome
- 250+ international clients served
- +3 more outcomes
Companies that use INITS Group
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
INITS Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
INITS Group partnerships and signals
Strategic signalScale indicators5 records
Recent moves4 records
Expansion highlights3 records
INITS Group competitors and assessment
Company assessmentBroad incumbents
- Catalent: Global CDMO offering preclinical and clinical bioproduction, formulation and regulatory support. Overlaps with INITS on the SMO-style bioproduction infrastructure side and adjacent CMC/regulatory services, though at much larger scale and broader modality coverage.
- Aenova Group: European pharmaceutical CDMO providing formulation, manufacturing, and related regulatory/CMC services. Comparable on the bioproduction and CMC-support dimensions of INITS' service portfolio, with broader scale and a strong EU base.
- Eurofins Scientific: Global life-sciences testing and CDMO group with strong biopharma services franchise covering CMC testing, regulatory support and quality. Significantly larger incumbent touching many of the same value-chain stages as INITS but at much greater scale.
- Recipharm: European-headquartered CDMO providing contract manufacturing and development services for biotech and pharma. Comparable on the bioproduction/CMC development side of INITS' offering, though operates at much larger infrastructure scale.
- CTI Clinical Trial & Consulting Services: Global CRO offering regulatory, clinical operations and consulting for biotech and specialty pharma. Overlaps with INITS in regulatory strategy, CMC and clinical-trial support, though at much larger scale and with broader clinical capabilities.
- NSF (formerly NSF-DBA): Global public-health and regulatory services group with pharma consulting, audit, quality and training offerings. Larger, more diversified incumbent that competes with INITS in regulatory/CMC consulting and QMS development for biotech clients.
- Piramal Pharma Solutions: Global CDMO offering drug substance and drug product development, manufacturing, and regulatory support across multiple modalities. Overlaps with INITS' CMC + SMO bioproduction capabilities while serving a broader client portfolio.
Direct peers
- Voisin Consulting Life Sciences: French-headquartered regulatory, CMC and quality consulting firm serving biotech and pharma clients. Direct competitor with comparable service breadth across regulatory affairs, CMC, and clinical strategy, and similar boutique positioning targeting European biotechs.
- PharmaLex Group: Global regulatory affairs, quality, pharmacovigilance and CMC consulting provider. Overlaps directly with INITS on regulatory submissions, CMC support, and QMS services, serving the same biotech and emerging-pharma client base across multiple geographies.
- Lachman Consulting Services: US-based consulting firm specializing in pharmaceutical regulatory affairs, CMC, GMP quality and compliance support. Comparable boutique offering targeting biotech and small-pharma regulatory/quality needs, much like INITS' Consulting pillar.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
INITS Group social profiles
Digital presenceINITS Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
INITS Group leadership team
Management profileNumber of profiles
INITS Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
INITS Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about INITS Group
What does INITS Group do?
INITS Group is a French service firm that provides consulting and a Shared Manufacturing Organization (SMO) offering to biotech and pharmaceutical companies. It delivers expertise across the pharmaceutical value chain in CMC (Chemistry, Manufacturing, and Controls), regulatory affairs, IMP (Investigational Medicinal Product) support, and quality assurance, and operates a dedicated bioproduction unit for preclinical and clinical trial material production.
Is INITS Group a public or private company?
INITS Group is a private company. It is classified as unknown and is currently operating.
When was INITS Group founded?
INITS Group was founded in 2013. It employs 11 to 50 people.
Where is INITS Group based?
INITS Group is headquartered in Montpellier, France, in the Europe region.
How does INITS Group make money?
Two revenue lines are on record. Consulting Services are the primary driver. The others are SMO Services.
Who are INITS Group's main competitors?
Broad incumbents on record are Catalent, Aenova Group, Eurofins Scientific, Recipharm, CTI Clinical Trial & Consulting Services, NSF (formerly NSF-DBA) and Piramal Pharma Solutions. Direct peers are Voisin Consulting Life Sciences, PharmaLex Group and Lachman Consulting Services.
Does INITS Group have an API?
No public API is recorded for INITS Group.
What industry is INITS Group in?
INITS Group's product category is Pharmaceutical Consulting. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 54161 and its SIC code is 8731.